Medical Digest & Congress Report

Clinical Updates for a novel preventative breast cancer vaccine - report from WVCDC 2025

07 May 2025

Contributed by Lukas

Olivera Finn shares her insights on clinical updates for a novel preventative breast cancer vaccine at the World Vaccine Congress Washington 2025.Vide...

Cell-Based Therapeutic Vaccination as Adjuvant Therapy for MGMT Unmethylated Glioblastoma - report from WVCDC 2025

07 May 2025

Contributed by Lukas

William Decker shares his insights on cell-based therapeutic vaccination as adjuvant therapy for MGMT unmethylated glioblastoma at the World Vaccine C...

Intranasal Universal Influenza Vaccine: Promising Data on Blocking Virus Transmission - report from WVCDC 2025

07 May 2025

Contributed by Lukas

Amy Aspelund shares her insights on intranasal universal influenza vaccines at the World Vaccine Congress Washington 2025.Video: https://medicaldigest...

Highlights of ACC.25

09 Apr 2025

Contributed by Lukas

Hadley Wilson, ACC Immediate Past President shares his insights on the key announcements and findings at the American College of Cardiology’s Annual...

Chronic Coronary Disease Management in 2025: What's New in the Guidelines? - report from ACC.25

09 Apr 2025

Contributed by Lukas

Benjamin H. Freed co-chaired an interesting session on Chronic Coronary Disease Management in 2025 at the American College of Cardiology’s Annual Sc...

Arrhythmia Management: Updates From Recent Practice Guidance Documents - report from ACC.25

09 Apr 2025

Contributed by Lukas

John K. Triedman shares his insights on the joint symposium of the Heart Rhythm Society and the American College of Cardiology, that will highlight re...

Chief Medical Officer's take on ACC.25

09 Apr 2025

Contributed by Lukas

Richard Kovacs shares his insights on key announcements and findings at the American College of Cardiology’s Annual Scientific Session.Video: https:...

Why lipoprotein(a) matters for clinical decisions and patient risk? - report from ACC.25

09 Apr 2025

Contributed by Lukas

Martha Gulati shares her insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scient...

Discussion on Optimizing Hypertension Management: We Need New Treatment and Interventions - report from ACC.25

08 Apr 2025

Contributed by Lukas

Paul K. Whelton shares his insights on optimizing hypertension management at the American College of Cardiology’s Annual Scientific Session.Video: h...

Lifetime Benefit by Control of Modifiable Risk Factors - report from ACC.25

08 Apr 2025

Contributed by Lukas

Christina Magnussen on individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potent...

Dapagliflozin Reduced LVMI in Patients with CKD : DECODE-CKD - report from ACC.25

08 Apr 2025

Contributed by Lukas

Tor Biering-Sørensen presented the analysis of the primary and secondary endpoint results of the DECODE-CKD at the American College of Cardiology’s...

Nurse-led behavior changes after heart attack cut subsequent event risk by 30% - report from ACC.25

08 Apr 2025

Contributed by Lukas

Giulia Magnani explains a nurse-coordinated intensive intervention program emphasizing lifestyle and behavioral changes after ACS was associated with ...

Lorundrostat shows continued promise against uncontrolled hypertension - report from ACC.25

08 Apr 2025

Contributed by Lukas

Luke Laffin on the phase 2b Advance-HTN study of lorundrostat, whose results were reported in a late-breaking clinical trials presentation at the Amer...

Shifting the Paradigm: Lipoprotein(a) in Cardiovascular Disease - report from ACC.25

08 Apr 2025

Contributed by Lukas

Alan Brown shares his insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scientifi...

ALIGN-AR reports positive outcomes with dedicated TAVI device for aortic regurgitation - report from ACC.25

08 Apr 2025

Contributed by Lukas

Raj Makkar explains data from 500 patients treated for aortic regurgitation with the Trilogy transcatheter aortic valve implantation system, point tow...

From Evidence Generation to Implementation: Tackling Unmet Need in ASCVD - report from ACC.25

08 Apr 2025

Contributed by Lukas

Ankeet S. Bhatt shares his insights how real-world evidence and implementation science can improve ASCVD care at the American College of Cardiology’...

Stepping into the future of care for patients with peripheral artery disease with the 2024 guidelines - report from ACC.25

04 Apr 2025

Contributed by Lukas

Heather L. Gornik shares her insights on future of care for patients with peripheral artery disease with the 2024 guidelines'. Video: https://medi...

Intravenous iron offers some benefits for some patients with heart failure - report from ACC.25

04 Apr 2025

Contributed by Lukas

Stefan D. Anker explains among iron-deficient patients with heart failure with reduced ejection fraction, receiving intravenous iron supplementation w...

Semaglutide improves walk distance for PAD patients with diabetes - report from ACC.25

04 Apr 2025

Contributed by Lukas

Marc P. Bonaca explains semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease and type 2 ...

TAVR comparable to open heart surgery after 5 years in low-risk patients - report from ACC.25

04 Apr 2025

Contributed by Lukas

Michael J. Reardon explains the new five-year data suggest transcatheter aortic valve replacement with a supra-annular, self-expanding valve is a safe...

Oral semaglutide reduces cardiovascular events by 14% at four years - report from ACC.25

04 Apr 2025

Contributed by Lukas

Darren K. McGuire explains people taking an oral formulation of semaglutide were 14% less likely than those taking a placebo to experience cardiovascu...

Research shows clopidogrel as better long-term therapy than aspirin after PCI - report from ACC.25

04 Apr 2025

Contributed by Lukas

Joo-Yong Hahn shares his insights on the research presented at the American College of Cardiology's Annual Scientific Session. People at high risk...

Low-dose apixiban comparable to full dose for preventing VTE recurrence in patients with cancer - report from ACC.25

04 Apr 2025

Contributed by Lukas

Isabelle Mahé shares her insights API-CAT trial were presented at the American College of Cardiology’s Annual Scientific Session.Video: https://med...

WARRIOR study: Intensive medical therapy does not help or harm women with chest pain - report from ACC.25

04 Apr 2025

Contributed by Lukas

Eileen M. Handberg, PhD, ARNP, FACC and C. Noel Bairey Merz, MD, FACC, FAHA shares their insights on the WARRIOR study, presented at the American Coll...

Redefining Risk of Recurrence: Latest advances with CDK4/6 inhibitors in HR+/HER2− early breast cancer

21 Mar 2025

Contributed by Lukas

Michael Gnant have been the Co-Chair of the highly successful, annual St Gallen Breast Cancer Conference in Vienna, and chaired a session about the la...

Why there is no such thing as a psychiatric diagnosis?

18 Mar 2025

Contributed by Lukas

Sami Timimi indicated in his presentation at the RCPsych in Scotland Winter Conference that formal psychiatric diagnostic systems should be abolished....

Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis

12 Mar 2025

Contributed by Lukas

Edoardo Ostinelli, Senior Researcher & Deputy Lead of Oxford Precision Psychiatry Lab at the Department of Psychiatry, University of Oxford, UK. H...

Social cognition in autism and ADHD

11 Mar 2025

Contributed by Lukas

Sven Bölte, professor of child and adolescent psychiatric science at Karolinska Institute, Stockholm, Sweden, renowned expert of neurodevelopmental d...

Addressing Comorbid Bipolar Disorder and ADHD

21 Feb 2025

Contributed by Lukas

Mark Jankelow, MSN, PMHNP-BC summarizes his presentation at Real Psychiatry 2025 on bipolar disorder and ADHD and shares his 20 years of experience wi...

Management of Multiple Myeloma at ASH 2024

24 Jan 2025

Contributed by Lukas

Professor Paul G. Richardson summarizes the most important highlights in the field of Multiple Myeloma treatment after the 2024 ASH Annual Meeting. Vi...

Highligths of SABCS 2024

08 Jan 2025

Contributed by Lukas

Kate Lathrop, MD discuss some of the high impact, clinically relevant, clinical trials that were presented at the San Antonio Breast Cancer Symposium ...

Early Breast Cancer Updates - report from SABCS2024

07 Jan 2025

Contributed by Lukas

Janice Tsang, MD discusses early breast cancer updates at San Antonio Breast Cancer Symposium 2024. Videó: https://medicaldigest.org/scientific-conte...

CLL Highlights from ASH 2024

07 Jan 2025

Contributed by Lukas

William G. Wierda, MD, PhD discusses current questions and state of the art treatement of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting....

The Aymara Gene: A Tale of High Altitude and Human Evolution - report from ASH2024

22 Dec 2024

Contributed by Lukas

Josef T. Prchal, MD investigated the genetic basis underlying elevated hemoglobin in Andean natives, Aymara, by using granulocyte transcriptome data f...

State of the Art Treatment in Polycythemia Vera - report from ASH2024

22 Dec 2024

Contributed by Lukas

Aaron Gerds, MD, MS discusses the state of the art treatment in polycythemia vera at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/sc...

State of the Art Treatment in Myelofibrosis - report from ASH2024

22 Dec 2024

Contributed by Lukas

Aaron Gerds, MD, MS discusses the state of the art treatment in myelofibrosis at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scienti...

Do GLP-1s Lower VTE Risk in People With Type 2 Diabetes? - report from ASH2024

22 Dec 2024

Contributed by Lukas

Cho Han Chiang, MD, MMSc presented an analysis at the 2024 ASH Annual Meeting, that shows GLP-1 receptor agonists led to a significant reduction in th...

24-hour Urine Testing does not Add Value to Multiple Myeloma Response Assessments - report from ASH2024

22 Dec 2024

Contributed by Lukas

Rahul Banerjee, MD, FACP comments on the role of 24-hour urine testing in assessing multiple myeloma treatment responses at the 2024 ASH Annual Meetin...

Bridging Gaps in Multiple Myeloma Care: A Community Oncologist's Guide to Navigating the Evolving Treatment Landscape - report from ASH2024

22 Dec 2024

Contributed by Lukas

Rahul Banerjee, MD, FACP discusses the state of the art treatment in Multiple Myeloma Care at the 2024 ASH Annual Meeting. Video: https://medicaldiges...

Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-base Platforms - report from ASH2024

22 Dec 2024

Contributed by Lukas

Matthew S. Davids, MD, MMSc discusses the state of the art treatment in chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Video: https://me...

State of the Art Treatment in Adult ALL - report from ASH2024

22 Dec 2024

Contributed by Lukas

Anand A. Patel, MD discusses the state of the art treatment in adult acute lymphoblastic leukemia at the 2024 ASH Annual Meeting. Video: https://medi...

State of the Art Treatment in Lymphoma - report from ASH2024

22 Dec 2024

Contributed by Lukas

Catherine S. Diefenbach, MD discusses the state of the art treatment in lymphoma care at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org...

Mastering the Art of Myelofibrosis Care: Expert Guidance, Clinical Experience, & Innovation for More Personalized Disease Control - report from ASH2024

22 Dec 2024

Contributed by Lukas

Prof. Francesco Passamonti discusses the state of the art treatment in myelofibrosis Care at the 2024 ASH Annual Meeting. Video: https://medicaldigest...

Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia - report from ASH2024

20 Dec 2024

Contributed by Lukas

Kerry A Rogers, MD discusses current questions and controversies in the management of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Vid...

Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia - report from ASH2024

20 Dec 2024

Contributed by Lukas

Michael J. Mauro, MD discusses current questions and controversies in the management of chronic myeloid leukemia at the 2024 ASH Annual Meeting. Video...

State of the Art Treatment in Myelodysplastic Syndromes - report from ASH2024

20 Dec 2024

Contributed by Lukas

Mikkael A. Sekeres, MD, MS discusses the state of the art treatment in MDS at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific...

Five-Year Analysis of the POLARIX Study - report from ASH2024

20 Dec 2024

Contributed by Lukas

Prof. Gilles Salles presented a 5-year analysis of the POLARIX study at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-conte...

Guiding Our Patient's Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR-Ts - report from ASH2024

20 Dec 2024

Contributed by Lukas

Prof. Gilles Salles discusses managing first relapse in diffuse large B-Cell lymphoma outside of CAR-Ts at the 2024 ASH Annual Meeting. Video: https:/...

Unraveling Data and Care Strategies for AL Amyloidosis - report from ASH2024

20 Dec 2024

Contributed by Lukas

Vaishali Sanchorawala, MD review the clinical challenges and intricacies of care associated with the management of light chain amyloidosis. Video: ht...

Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma - report from ASH2024

20 Dec 2024

Contributed by Lukas

Joshua Brody, MD discusses the advancing field of bispecific antibodies in third-line relapsed/refractory follicular lymphoma. Video: https://medicald...

Smoking Tied to Worsened Disease Progression in Myelodysplastic Syndromes - report from ASH2024

20 Dec 2024

Contributed by Lukas

Sangeetha Venugopal MD,MS discusses that smoking intensity and duration in patients with myelodysplastic syndromes were tied to distinct genetic mutat...

Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma - report from ASH2024

20 Dec 2024

Contributed by Lukas

Martin Hutchings, MD, PhD discusses the role of CAR T-Cell therapy and bispecific antibodies in the management of lymphoma at the 2024 ASH Annual Meet...

Estrogen Receptor Mutations in HR+ Advanced Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Virginia Kaklamani, MD, DSc discusses estrogen receptor mutations in HR+ advanced breast cancer and generation practice recommendations on mutation sc...

Anthracyclines May Improve Survival in High-Risk Breast Cancer, But Risks Must Be Weighed - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Nan Chen, MD explains patients with early-stage, node-negative, hormone receptor positive, HER2- negative breast cancer who have a high risk of recurr...

Immunotherapy: Explore Inroads for ER-positive Disease, Challenges Ahead - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Heather McArthur, MD, MPH discusses immunotherapy panel discussion to explore inroads for ER-positive disease, challenges ahead at San Antonio Breast ...

The Winding Road of Immune Biomarkers in Early Breast Cancer - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Sherene Loi, MD discusses immune biomarkers in early breast cancer at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scien...

Palbociclib Plus Endocrine Therapy Beats Chemo in HR+/HER2− Metastatic Breast Cancer - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Prof. Sibylle Loibl presented the findings from the phase 3 PADMA clinical trial at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldi...

COMET Trial Finds Active Monitoring Is a Viable Option for Some Patients With Low-risk DCIS - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Shelley Hwang, MD, MPH discusses active monitoring instead of upfront surgery may be a viable option for patients with hormone receptor-positive, HER2...

Palbociclib Shows Benefit in HR+ HER2+ Metastatic Breast Cancer – the PATINA Trial - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Otto Metzger, MD presented late-breaking results of the phase 3 PATINA trial showing addition of CDK4/6 inhibitor palbociclib to standard therapy led ...

Breast Cancer in Young Women - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Matteo Lambertini, MD, PhD discusses an educational session focus on the management of breast cancer in young women at San Antonio Breast Cancer Sympo...

The Future of Cancer Genetics Is Here - Reversion Mutations in BRCA1/2 in Response to Therapy - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Katherine L. Nathanson, MD discusses reversion mutations in BRCA1/2 in response to therapy at San Antonio Breast Cancer Symposium 2024. Video: https:/...

Next-generation SERD Protects Against Progression in Some Patients With Advanced Breast Cancer Resistant to Standard Hormone Therapy - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Kate Lathrop, MD discusses results from the phase III EMBER-3 clinical trial presented at San Antonio Breast Cancer Symposium 2024. Video: https://med...

Clinical Controversies: Omission of Axillary Staging in ER Positive Breast Cancer: Implications on Adjuvant Therapies - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Monica Morrow, MD, FACS discusses omission of axillary staging in ER positive breast cancer at San Antonio Breast Cancer Symposium 2024. Video: https:...

Risk Reduction and Early Detection: Updates on Breast Cancer Screening - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Ismail Jatoi, MD, PhD, FACS discusses updates on breast cancer screening at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org...

Efficacy and Safety of Trastuzumab Deruxtecan vs Physician’s Choice of Chemotherapy by Pace of Disease Progression on Prior Endocrine-based Therapy - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Prof. Giuseppe Curigliano presents the data of the DESTINY-Breast06 at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scie...

Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Sara A Hurvitz, MD, FACP on the role of endocrine-based therapy in the management of breast cancer at San Antonio Breast Cancer Symposium 2024. Video:...

Immediate Surgery Lowers Local Recurrence in Older Breast Cancer Population - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Prof. Robert Hills presents a comprehensive patient-level meta-analysis of three randomized trials demonstrated that compared with surgery deferral, i...

PARP Inhibition Shows Long-term Survival Benefits for Patients With High-risk, BRCA-positive Breast Cancer in OlympiA Trial - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Judy E. Garber, MD, MPH presents updated results of the OlympiA study at San Antonio Breast Cancer Symposium 2024. The new analysis provides further s...

Daratumumab Shows Better Outcomes Than Active Monitoring for Smoldering Multiple Myeloma - report from ASH2024

20 Dec 2024

Contributed by Lukas

Prof. Meletios-Athanasios Dimopoulos discusses the results of the AQUILA trial, a phase 3 randomized study presented at the 2024 ASH Annual Meeting. N...

Blinatumomab in Combination With Chemotherapy May Improve Survival in Pediatric Patients Newly Diagnosed With B-Cell Precursor ALL - report from ASH2024

20 Dec 2024

Contributed by Lukas

Sumit Gupta, MD, PhD discusses results from the phase 3 Children’s Oncology Group Study AALL1731 presented at the 2024 ASH Annual Meeting. The study...

Guiding Our Patient's Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR-Ts - report from ASH2024

20 Dec 2024

Contributed by Lukas

Gareth Gregory, MBBS, PhD on the options for treatment of diffuse large B-cell lymphoma, which have expanded in recent years, particularly with the em...

High-Fiber NUTRIVENTION Study for Delaying Progression of Myeloma - report from ASH2024

20 Dec 2024

Contributed by Lukas

Urvi A. Shah, MD discusses the NUTRIVENTION study, the current result from the trial, how it may delay progression of myeloma, and the importance of h...

Fixed-Duration Acalabrutinib/Venetoclax in Fit Patients With CLL: AMPLIFY Trial - report from ASH2024

20 Dec 2024

Contributed by Lukas

Jennifer R. Brown, MD, PhD explains the interim analysis of the multicenter, open-label, randomized, phase 3 AMPLIFY trial presented at the 2024 ASH A...

Escape the Amyloid Maze: Unraveling Data and Care Strategies for AL Amyloidosis - report from ASH2024

20 Dec 2024

Contributed by Lukas

Suzanne Lentzsch, MD, PhD explains a symposium presented at the 2024 ASH Annual Meeting on the clinical challenges and intricacies of care associated ...

How to improve immunization in children and adolescents? - report from CHEST2024

12 Nov 2024

Contributed by Lukas

Professor Robert Jacobson shares his thoughts on how to improve immunization in children and adolescents. Video: https://medicaldigest.org/scientific-...

New developments in neurendocrine tumours

11 Nov 2024

Contributed by Lukas

Professor Jennifer Chan shares her insights on the new developments in neurendocrine tumours. She talks about studies like CABINET and NETTER-2. Video...

Duchenne Muscular Dystrophy, Then and Now: Lessons from Respiratory Medicine - report from CHEST2024

04 Nov 2024

Contributed by Lukas

David J. Birnkrant, MD, FCCP held the prestigious Margaret Pfrommer Endowed Memorial Lecture In Home-Based Mechanical Ventilation at CHEST 2024. We as...

Update in Vaccines for RSV, COVID, Influenza - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Aanchal Kapoor, MD, FCCP shares her thoughts on updates in RSV, COVID and influenza vaccines. Video: https://medicaldigest.org/scientific-contents/int...

How to manage acute PE? Follow the five D! - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Bhavinkumar Dalal, FACP, MBBS, MD, FCCP chaired a very interesting presentation on controversies for the management of acute pulmonary embolism at CHE...

Breathing Easier: The Evolution and Future of Asthma Care - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Sandhya Khurana, MD, FCCP held the prestigious Mark J. Rosen, MD, Master FCCP Endowed Memorial Lecture at CHEST 2024. We asked her about the lecture a...

Importance of Vaccinations for Patients With Pulmonary Conditions - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Shekhar Ghamande, MBBS, MD, FCCP shares his thoughts on the importance of vaccinations for patients with pulmonary conditions. The important role of t...

Comparison of GINA and EPR-4 Asthma Guidelines - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Shahid Sheikh, MD, FCCP shares his thoughts on the GINA and EPR-4 Asthma Guidelines. Video: https://medicaldigest.org/scientific-contents/interview:co...

New directions in Asthma and COPD - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Monica Kraft, MD, FCCP shares her thoughts on the new directions in Asthma and COPD. Video: https://medicaldigest.org/scientific-contents/interview:ne...

Interplay of Pregnancy and Sleep - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Ghada Bourjeily, MD, FCCP participated in an interesting session about precision medicine for sleep disorders in women, and eplaneined her thoughts on...

Evaluation and Management of VTE in Pregnancy - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Lisa Moores, MD, FCCP shares her thoughts on evaluation and management of VTE in pregnancy. Video: https://medicaldigest.org/scientific-contents/inter...

Beyond Bronchodilators: Bronchoscopic Management of COPD - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Jonathan Kurman, MBA, MD, FCCP shares his thoughts on bronchoscopic management of COPD. Video: https://medicaldigest.org/scientific-contents/intervie...

Portopulmonary Hypertension: How Should We Think About it? - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Hilary Dubrock, MD shares her thoughts on portopulmonary hypertension and explains how we should think about it. Video: https://medicaldigest.org/scie...

Hemodynamic Assessment in Pulmonary Arterial Hypertension - Obtaining the Most Out of Right Heart Catheterization - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Adriano Tonelli, MD shares his thoughts on hemodynamic assessment in pulmonary arterial hypertension. Video: https://medicaldigest.org/scientific-cont...

The role of LABA/LAMA and triple therapy for patients with COPD in GOLD Group E - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Nicola Hanania, MS, MD, FCCP participated in a pro-con debate on the role of LABA/LAMA and triple therapy in patients with COPD. He shared his thought...

CHEST Guidelines on Biologics for Severe Asthma: Evidence, Recommendations, and Clinical Implications - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Megan Conroy, MD, MAEd, FCCP and Amber Oberle, MD share their thoughts about CHEST guidelines on #biologics for severe asthma. Video: https://medicald...

Advanced Management Strategies in Severe Asthma and COPD - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Muhammad Adrish, MBA, MD, FCCP shares his thoughts on personalized treatment strategies for severe asthma and COPD. Video: https://medicaldigest.org/s...

Lymphoma highlights of the ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Maria Gomes da Silva shares his insights on the lymphoma highlights of the ESMO 2024 Congress. She talks about topics like bispecific antibo...

Quadruplet therapy is becoming the new standard of treatment - Multiple myeloma highlights at ESMO2024

24 Oct 2024

Contributed by Lukas

Professor Xavier Leleu shares his insights about the importance of quadruple therapy in multiple myeloma. Video: https://medicaldigest.org/scientific...

Melanoma highlights of the ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Jessica Hassel shares his insights on the melanoma highlights of the ESMO 2024 Congress. She talks about studies like CheckMate067, CheckMat...

Radiation therapy for breast cancer can be safely shortened by changing technique - report from ESMO2024

24 Oct 2024

Contributed by Lukas

Professor Sofia Rivera shares his insights at ESMO 2024 about the phase three HypoG-01 study looking at hypofractionated radiation therapy for breast ...

Prostate Cancer highlights of ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Oliver Sartor shares his insights on the prostate cancer highlights of the ESMO 2024 Congress. Video: https://medicaldigest.org/scientific-c...

Efficacy of 177Lu-PNT2002 in PSMA-Positive mCRPC Following Progression on an Androgen-Receptor Pathway Inhibitor - report from ESMO2024

24 Oct 2024

Contributed by Lukas

Professor Oliver Sartor shares his insights on the SPLASH study. Video: https://medicaldigest.org/scientific-contents/interview:efficacy-177lu-pnt2002...

RCC highlights of ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Camillo Porta shares his insights on the RCC highlights of the ESMO 2024 Congress. He talks about studies like TiNivo-2, CONTACT-03, SUNNIFO...

Breast cancer, metastatic highlights of the ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Giampaolo Bianchini shares his insights on the breast cancer metastatic highlights of the ESMO 2024 Congress. Video: https://medicaldigest....

Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in Previously Treated HER2-positive mBC Including a Large Cohort of Patients with Brain Metastases

24 Oct 2024

Contributed by Lukas

Professor Giampaolo Bianchini shares his insights on the DESTINY-Breast12 study. Video: https://medicaldigest.org/scientific-contents/interview:substa...